Bladder cancer is one of the most common malignant tumors in urinary system, and the treatment faces huge challenges.

Volrustomig is under clinical development by AstraZeneca and currently in Phase II for Malignant Neoplasms. According to GlobalData, Phase II drugs for Malignant Neoplasms does not have sufficient ...

A urinary bladder stone, also referred to as bladder calculus, is a hard mass of minerals that accumulates in the bladder. It happens when there is a buildup of urine in the bladder for a long ...

malignant pleural mesothelioma, follicular thyroid cancer, human epidermal growth factor receptor 2 positive breast cancer (HER2+ breast cancer), nose neoplasms, unspecified ophthalmological disorders ...

An intraductal papillary mucinous neoplasm (IPMN) is a benign or noncancerous ... which means they may lead to pancreatic cancer. Malignant and high risk pancreatic tumors typically require ...

gDepartment of Pathology and Stanford Center for Genomics and Personalized Medicine, Stanford University School of Medicine, Stanford, CA, USA, hStanford Cancer Institute, Stanford University School ...

Malignant pleural mesothelioma ... regions is comparable to that of other well-known neoplasms, such as transitional cell carcinoma of the bladder and bone osteosarcoma. In Japan and other ...

Malignant neoplasm of breast Malignant neoplasm of breast. ICD-codes: ICD-9: 174-175 ICD-10: C50. Malignant neoplasm of bladder Malignant neoplasm of bladder. ICD-code: ICD-9: 188 ICD-10: C67. Dis. of ...

Head and neck neoplasms have a poor prognosis because of their late diagnosis. Finding a biomarker to detect these tumors in an early phase could improve the prognosis and survival rate. This ...